Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-03-05 Sale | 2024-03-06 7:39 pm | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD | 12,991 | $3.4354 | $44,629 | 447,839 (Direct) | View |
| 2020-12-10 Sale | 2020-12-11 9:00 pm | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 25,000 | $55 | $1,375,000 | 30,000 (Direct) | View |
| 2020-09-29 Sale | 2020-10-01 8:00 pm | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 10,000 | $50 | $500,000 | 55,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-08 Exercise | 2024-10-10 5:47 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD | 5,000 | $1.98 | 253,290 (Direct) | View |
| 2024-10-08 Exercise | 2024-10-10 5:47 pm | N/A 2024-10-13 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD | 5,000 | $0 | 253,290 (Direct) | View |
| 2024-03-04 Option Award | 2024-03-06 7:39 pm | N/A 2034-03-04 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD | 332,528 | $0 | 447,839 (Direct) | View |
Ownership | 2024-03-06 7:38 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN Chief Commercial Officer, MRD | 0 | $0 | 430,074 (Direct) | View |
| 2021-03-04 Option Award | 2021-03-08 7:00 pm | N/A 2021-03-04 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 32,052 | $0 | 32,052 (Direct) | View |
| 2020-12-10 Exercise | 2020-12-11 9:00 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 25,000 | $1.98 | 30,000 (Direct) | View |
| 2020-12-10 Exercise | 2020-12-11 9:00 pm | N/A 2024-10-13 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 25,000 | $0 | 30,000 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 8:00 pm | N/A N/A | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 10,000 | $1.98 | 55,000 (Direct) | View |
| 2020-09-29 Exercise | 2020-10-01 8:00 pm | N/A 2024-10-13 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 10,000 | $0 | 55,000 (Direct) | View |
Ownership | 2020-08-14 9:00 pm | N/A 2024-10-13 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 0 | $0 | 127,224 (Direct) | View |
| 2020-08-13 Option Award | 2020-08-14 9:00 pm | N/A 2030-08-13 | Adaptive Biotechnologies Corp | ADPT | BOBULSKY SUSAN SVP, Diagnostics, clonoSEQ | 20,000 | $0 | 20,000 (Direct) | View |